Fundies.
English

Segment disclosures

Company overview

CENTESSA PHARMACEUTICALS PLC

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 14 retained observations 10 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnta:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-310 USD20260505Open filing evidence
2025-01-01 – 2025-12-3115000000 USD20260331Open filing evidence
2025-07-01 – 2025-09-300 USD20251105Open filing evidence
2025-01-01 – 2025-09-3015000000 USD20251105Open filing evidence
2025-04-01 – 2025-06-300 USD20250812Open filing evidence
2025-01-01 – 2025-06-3015000000 USD20250812Open filing evidence
2025-01-01 – 2025-03-3115000000 USD20260505Open filing evidence
2024-01-01 – 2024-12-310 USD20260331Open filing evidence
2024-07-01 – 2024-09-300 USD20251105Open filing evidence
2024-01-01 – 2024-09-300 USD20251105Open filing evidence
2024-04-01 – 2024-06-300 USD20250812Open filing evidence
2024-01-01 – 2024-06-300 USD20250812Open filing evidence
2024-01-01 – 2024-03-310 USD20250514Open filing evidence
2023-01-01 – 2023-12-316853000 USD20250324Open filing evidence